Prospective evaluation of hydrocortisone and suramin in patients with androgen-independent prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Hydrocortisone
  • Prostatic Neoplasms
  • Suramin
  • Testosterone

abstract

  • Suramin has limited efficacy in patients with androgen-independent prostate cancer who have had disease progression after hydrocortisone.

publication date

  • January 1995

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7545218

Additional Document Info

start page

  • 2208

end page

  • 13

volume

  • 13

number

  • 9